Evaluation of the Concentration of Selected Elements in Patients with Cancer of the Reproductive Organs with Respect to Treatment Stage—Preliminary Study
Open Access
Abstract
(1) Background: The aim of this study was to assess the concentrations of selected elements in female patients with cancer of the reproductive organs, taking into account the stage of treatment. (2) Methods: The study sample consisted of 51 patients with advanced endometrial cancer and ovarian cancer, undergoing chemotherapy. The median age of the studied patients with endometrial cancer was 66.0 years (IQR: from 60.75 to 70.25), and with ovarian cancer―60.0 years (IQR: from 49.0 to 64.0). Each of the qualified women, after consent to participate in the study, had her blood drawn several times (before surgery, the first course of chemotherapy, the third course of chemotherapy, and the sixth course of chemotherapy) in order to determine serum levels of macro- and micronutrients (Na, Mg, Ca, Zn, P, Cu, Fe, Cd, Ni, and Sr). (3) Results: In the study group of patients with cancer of the reproductive tract, the concentrations of iron (p < 0.05). (4) Conclusions: In the studied group of patients with ovarian and endometrial cancer, the applied chemotherapy significantly changed the concentrations of Fe, Na, and Ni, regardless of the type of tumor. Changes in Mg and Cd concentrations resulted from the interaction between the stage of chemotherapy and the type of cancer. The results of serum concentrations of selected elements in women with cancer of the reproductive organs may help understand the physiological changes resulting from the applied chemotherapy.Keywords
Funding Information
- Minister of Science and Higher Education (002/RID/2018/19)
This publication has 47 references indexed in Scilit:
- Cancer statistics, 2013CA: A Cancer Journal for Clinicians, 2013
- Supplement use during an intergroup clinical trial for breast cancer (S0221)Breast Cancer Research and Treatment, 2013
- Impact of Long-Term Serum Platinum Concentrations on Neuro- and Ototoxicity in Cisplatin-Treated Survivors of Testicular CancerJournal of Clinical Oncology, 2012
- Effects of iron deficiency and iron overload on angiogenesis and oxidative stress—a potential dual role for iron in breast cancerFree Radical Biology and Medicine, 2011
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatmentCancer Treatment Reviews, 2009
- Does iron have a role in breast cancer?The Lancet Oncology, 2008
- Cisplatin Nephrotoxicity: A ReviewThe American Journal of the Medical Sciences, 2007
- International Agency for Research on Cancer (IARC) 〈http://www.iarc.fr〉Toxicologic Pathology, 2006
- Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients?: Results from the Mayo Clinic lung cancer cohortLung Cancer, 2005
- Dietary intake and health effects of selected toxic elementsBrazilian Journal of Plant Physiology, 2005